Baxter International (BAX) EBIT (2016 - 2024)
Historic EBIT for Baxter International (BAX) over the last 16 years, with Q4 2024 value amounting to $959.0 million.
- Baxter International's EBIT rose 4845.2% to $959.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 billion, marking a year-over-year increase of 35403.11%. This contributed to the annual value of $14.0 million for FY2024, which is 9801.98% down from last year.
- According to the latest figures from Q4 2024, Baxter International's EBIT is $959.0 million, which was up 4845.2% from $1.0 billion recorded in Q3 2024.
- Baxter International's EBIT's 5-year high stood at $1.0 billion during Q3 2024, with a 5-year trough of -$2.9 billion in Q3 2022.
- Moreover, its 5-year median value for EBIT was $360.5 million (2020), whereas its average is $205.9 million.
- Its EBIT has fluctuated over the past 5 years, first crashed by 145652.17% in 2022, then surged by 616470.59% in 2024.
- Baxter International's EBIT (Quarter) stood at $406.0 million in 2020, then crashed by 94.33% to $23.0 million in 2021, then plummeted by 1456.52% to -$312.0 million in 2022, then surged by 307.05% to $646.0 million in 2023, then soared by 48.45% to $959.0 million in 2024.
- Its EBIT stands at $959.0 million for Q4 2024, versus $1.0 billion for Q3 2024 and $1.0 billion for Q2 2024.